---
ticker: "IDNA"
name: "iShares Genomics Immunology and Healthcare ETF"
url: "https://etf.net/etf/IDNA"
grade: "B"
score: 56
graded_at: "2026-10-12"
category: "Biotech & Genomics"
category_rank: "7 of 17"
methodology: "https://etf.net/methodology"
---

# IDNA: iShares Genomics Immunology and Healthcare ETF

Grade **B**, Score 56 of 100. Rank 7 of 17 in Biotech & Genomics.

Graded Oct 12, 2026.

## Grade pillars

| Pillar | Score | Category rank |
| --- | --- | --- |
| Cost | 56 | 7 of 17 |
| Mission | Not scored | — |
| Risk | 67 | 6 of 17 |
| Tradability | 53 | 8 of 17 |
| Holdings | 46 | 13 of 17 |
| Durability | 62 | 7 of 17 |

## Top holdings

The fund holds 62 positions. These are the largest 30, by weight.

| # | Ticker | Name | Weight |
| --- | --- | --- | --- |
| 1 | MRNA | Moderna | 13.23% |
| 2 | TWST | Twist Bioscience | 6.44% |
| 3 | IOVA | Iovance Biotherapeutics Inc | 4.96% |
| 4 | GMAB.CO | Genmab | 4.14% |
| 5 | RVMD | Revolution Medicines | 3.55% |
| 6 | IBRX | Immunitybio | 3.46% |
| 7 | MRK | Merck & Co Inc | 3.36% |
| 8 | 4502.T | Takeda Pharmaceutical | 3.35% |
| 9 | REGN | Regeneron Pharmaceuticals | 3.28% |
| 10 | BAYN.DE | Bayer AG | 3.27% |
| 11 | CAI | Caris Life Sciences | 3.19% |
| 12 | VRTX | Vertex Pharmaceuticals | 3.18% |
| 13 | EXEL | Exelixis Inc | 3.17% |
| 14 | INCY | Incyte Corp | 3.07% |
| 15 | BNTX | Biontech SE Adr | 3.07% |
| 16 | ROP.SW | Roche Ps Par AG | 2.91% |
| 17 | IDYA | Ideaya Biosciences | 2.63% |
| 18 | ABCL | Abcellera Biologics | 2.58% |
| 19 | GSK.L | Glaxosmithkline | 2.49% |
| 20 | SAN.PA | Sanofi SA | 2.48% |
| 21 | IPN.PA | Ipsen SA | 2.44% |
| 22 | RCUS | Arcus Biosciences | 1.79% |
| 23 | NVAX | Novavax | 1.75% |
| 24 | 4528.T | Ono Pharmaceutical | 1.40% |
| 25 | VIR | Vir Biotechnology | 1.36% |
| 26 | CRSP | Crispr Therapeutics AG | 1.34% |
| 27 | NUVB | Nuvation Bio Class A | 1.08% |
| 28 | JANX | Janux Therapeutics | 0.92% |
| 29 | PSNL | Personalis | 0.87% |
| 30 | KURA | Kura Oncology | 0.80% |

Source: etf.net, https://etf.net/etf/IDNA. Please cite the page URL.